Guo Weihua, Sheng Jiayuan, Feng Xueyang
Department of Biological Systems Engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, United States.
Comput Struct Biotechnol J. 2017 Jan 19;15:161-167. doi: 10.1016/j.csbj.2017.01.006. eCollection 2017.
With the breakthroughs in biomolecular engineering and synthetic biology, many valuable biologically active compound and commodity chemicals have been successfully manufactured using cell-based approaches in the past decade. However, because of the high complexity of cell metabolism, the identification and optimization of rate-limiting metabolic pathways for improving the product yield is often difficult, which represents a significant and unavoidable barrier of traditional metabolic engineering. Recently, some engineering approaches were proposed as alternative strategies to solve this problem. In brief, by reconstituting a biosynthetic pathway in a cell-free environment with the supplement of cofactors and substrates, the performance of each biosynthetic pathway could be evaluated and optimized systematically. Several value-added products, including chemicals, nutraceuticals, and drug precursors, have been biosynthesized as proof-of-concept demonstrations of metabolic engineering. This mini-review summarizes the recent progresses on the emerging topic of metabolic engineering and comments on the potential application of cell-free technology to speed up the "design-build-test" cycles of biomanufacturing.
随着生物分子工程和合成生物学的突破,在过去十年中,许多有价值的生物活性化合物和商品化学品已成功通过基于细胞的方法制造出来。然而,由于细胞代谢的高度复杂性,识别和优化限速代谢途径以提高产品产量往往很困难,这是传统代谢工程中一个重大且不可避免的障碍。最近,一些工程方法被提出作为解决这一问题的替代策略。简而言之,通过在无细胞环境中补充辅因子和底物来重建生物合成途径,可以系统地评估和优化每个生物合成途径的性能。包括化学品、营养保健品和药物前体在内的几种增值产品已被生物合成,作为代谢工程概念验证的示范。本综述总结了代谢工程这一新兴主题的最新进展,并对无细胞技术在加速生物制造“设计-构建-测试”周期方面的潜在应用进行了评论。